United States Fondaparinux Market Report 2016

Publisher Name :
Date: 07-Oct-2016
No. of pages: 116
Inquire Before Buying

Notes:

Sales, means the sales volume of Fondaparinux

Revenue, means the sales value of Fondaparinux

This report studies sales (consumption) of Fondaparinux in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Pfizer, Inc. (US)

- Bayer Healthcare AG (Germany)

- GlaxoSmithKline Plc. (UK)

- Boehringer Ingelheim (Germany)

- Sanofi S.A. (France)

- Abbott India Limited (India)

- Aspen Holdings (South Africa)

- Bristol-Myers Squibb Company (US)

- Eisai Inc. (US)

- Mitsubishi Tanabe Pharma Corporation (Japan)

- Teva Pharmaceutical Industries Ltd. (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Fondaparinux in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Fondaparinux Market Report 2016

Table of Contents
United States Fondaparinux Market Report 2016
1 Fondaparinux Overview
1.1 Product Overview and Scope of Fondaparinux
1.2 Classification of Fondaparinux
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Fondaparinux
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Fondaparinux (2011-2021)
1.4.1 United States Fondaparinux Sales and Growth Rate (2011-2021)
1.4.2 United States Fondaparinux Revenue and Growth Rate (2011-2021)
2 United States Fondaparinux Competition by Manufacturers
2.1 United States Fondaparinux Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Fondaparinux Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Fondaparinux Average Price by Manufactures (2015 and 2016)
2.4 Fondaparinux Market Competitive Situation and Trends
2.4.1 Fondaparinux Market Concentration Rate
2.4.2 Fondaparinux Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Fondaparinux Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Fondaparinux Sales and Market Share by Type (2011-2016)
3.2 United States Fondaparinux Revenue and Market Share by Type (2011-2016)
3.3 United States Fondaparinux Price by Type (2011-2016)
3.4 United States Fondaparinux Sales Growth Rate by Type (2011-2016)
4 United States Fondaparinux Sales (Volume) by Application (2011-2016)
4.1 United States Fondaparinux Sales and Market Share by Application (2011-2016)
4.2 United States Fondaparinux Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Fondaparinux Manufacturers Profiles/Analysis
5.1 Pfizer, Inc. (US)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Fondaparinux Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer, Inc. (US) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
5.2.2 Fondaparinux Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Bayer Healthcare AG (Germany) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
5.3.2 Fondaparinux Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 GlaxoSmithKline Plc. (UK) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
5.4.2 Fondaparinux Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Boehringer Ingelheim (Germany) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
5.5.2 Fondaparinux Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Sanofi S.A. (France) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
5.6.2 Fondaparinux Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Abbott India Limited (India) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
5.7.2 Fondaparinux Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Aspen Holdings (South Africa) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
5.8.2 Fondaparinux Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Bristol-Myers Squibb Company (US) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
5.9.2 Fondaparinux Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Eisai Inc. (US) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
5.10.2 Fondaparinux Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)
6 Fondaparinux Manufacturing Cost Analysis
6.1 Fondaparinux Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Fondaparinux
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Fondaparinux Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Fondaparinux Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Fondaparinux Market Forecast (2016-2021)
10.1 United States Fondaparinux Sales, Revenue Forecast (2016-2021)
10.2 United States Fondaparinux Sales Forecast by Type (2016-2021)
10.3 United States Fondaparinux Sales Forecast by Application (2016-2021)
10.4 Fondaparinux Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Fondaparinux
Table Classification of Fondaparinux
Figure United States Sales Market Share of Fondaparinux by Type in 2015
Table Application of Fondaparinux
Figure United States Sales Market Share of Fondaparinux by Application in 2015
Figure United States Fondaparinux Sales and Growth Rate (2011-2021)
Figure United States Fondaparinux Revenue and Growth Rate (2011-2021)
Table United States Fondaparinux Sales of Key Manufacturers (2015 and 2016)
Table United States Fondaparinux Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Fondaparinux Sales Share by Manufacturers
Figure 2016 Fondaparinux Sales Share by Manufacturers
Table United States Fondaparinux Revenue by Manufacturers (2015 and 2016)
Table United States Fondaparinux Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Fondaparinux Revenue Share by Manufacturers
Table 2016 United States Fondaparinux Revenue Share by Manufacturers
Table United States Market Fondaparinux Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Fondaparinux Average Price of Key Manufacturers in 2015
Figure Fondaparinux Market Share of Top 3 Manufacturers
Figure Fondaparinux Market Share of Top 5 Manufacturers
Table United States Fondaparinux Sales by Type (2011-2016)
Table United States Fondaparinux Sales Share by Type (2011-2016)
Figure United States Fondaparinux Sales Market Share by Type in 2015
Table United States Fondaparinux Revenue and Market Share by Type (2011-2016)
Table United States Fondaparinux Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Fondaparinux by Type (2011-2016)
Table United States Fondaparinux Price by Type (2011-2016)
Figure United States Fondaparinux Sales Growth Rate by Type (2011-2016)
Table United States Fondaparinux Sales by Application (2011-2016)
Table United States Fondaparinux Sales Market Share by Application (2011-2016)
Figure United States Fondaparinux Sales Market Share by Application in 2015
Table United States Fondaparinux Sales Growth Rate by Application (2011-2016)
Figure United States Fondaparinux Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Fondaparinux Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Fondaparinux Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Fondaparinux Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Fondaparinux Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Fondaparinux Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Fondaparinux Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Fondaparinux Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Fondaparinux Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Fondaparinux Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Fondaparinux Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Fondaparinux Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Fondaparinux Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Fondaparinux
Figure Manufacturing Process Analysis of Fondaparinux
Figure Fondaparinux Industrial Chain Analysis
Table Raw Materials Sources of Fondaparinux Major Manufacturers in 2015
Table Major Buyers of Fondaparinux
Table Distributors/Traders List
Figure United States Fondaparinux Production and Growth Rate Forecast (2016-2021)
Figure United States Fondaparinux Revenue and Growth Rate Forecast (2016-2021)
Table United States Fondaparinux Production Forecast by Type (2016-2021)
Table United States Fondaparinux Consumption Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Global Medical Shoes Market: Analysis By Product Type, By End User, By Distribution Channel, By Region, By Country: Opportunities and Forecast (2017-2022) - By Product Type (Diabetic Shoes, Rheumatoid Arthritis Shoes, Hallux Valgus, Others), By End User (Women, Men), By distribution Channel (Hospitals & Clinics, Online Retail, Specialty Stores, Departmental Stores, Super & Hypermarkets), By Region (North America, Europe, APAC, ROW), By Country (U.S, Canada, U.K., Germany, France, Italy, China, India, Japan)
    Published: 25-May-2017        Price: US 2400 Onwards        Pages: 180
    Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Medical Shoes Market; By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, Italy, China, India, Japan) Orthopedic Shoes are gaining significant importance as the next major development in Medic......
  • EMEA (Europe, Middle East and Africa) Minimally Invasive Surgical Instrument Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 128
    In this report, the EMEA Minimally Invasive Surgical Instrument market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Minimally Invasive Surgical Instrument for these regions, from 2012 to 2022 (forecast) - Europe: Germany, ......
  • EMEA (Europe, Middle East and Africa) Neonatal Care Equipment Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 111
    In this report, the EMEA Neonatal Care Equipment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Neonatal Care Equipment for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and ......
  • EMEA (Europe, Middle East and Africa) Neurostimulator Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the EMEA Neurostimulator market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Neurostimulator for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - M......
  • United States Cardiac Surgery Instruments Market Report 2017
    Published: 24-May-2017        Price: US 3800 Onwards        Pages: 111
    In this report, the United States Cardiac Surgery Instruments market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and gro......
  • Asia-Pacific Ultrasonic Liposuction Instrument Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 117
    In this report, the Asia-Pacific Ultrasonic Liposuction Instrument market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Ultrasonic Liposuction Instrument for these regions, from 2012 to 2022 (forecast), including - China - ......
  • Global Vaccine Refrigerators Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 24-May-2017        Price: US 3480 Onwards        Pages: 163
    A vaccine refrigerator is a refrigeration unit designed specifically for storing vaccines and other temperature-sensitive medical supplies, most of which need to be held at temperatures lower than that of a conventional fridge. The unit provides extremely stable low temperatures to prevent degradation of vaccines and other products, along with options like alarms and backup power to provide complete protection. In the report we mainly calculated the refrigerator range from 2°to 8°. ......
  • United States Cardiac Rhythm Management Device Market Report 2017
    Published: 24-May-2017        Price: US 3800 Onwards        Pages: 111
    In this report, the United States Cardiac Rhythm Management Device market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share an......
  • EMEA (Europe, Middle East and Africa) Pregnancy Test Meter Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 108
    In this report, the EMEA Pregnancy Test Meter market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Pregnancy Test Meter for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelu......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs